Riskpilot← Back to searchSign inGet full accessAntaros Medical AB
ABActiveOrg 5569769457Förändringens Gata 10Research and experimental development on natural sciences and engineering · NACE 7210Est. 2014115 employees
Revenue 2024
SEK 142,7M
+22% vs 2023
EBITDA margin
14.3%
+137% vs 2023
Equity ratio
10.0%
Financial strength
Net profit 2024
SEK 1,9M
+155% vs 2023
| Revenue | SEK 142,7M | +22% |
| EBITDA | SEK 20,3M | +137% |
| Net profit | SEK 1,9M | +155% |
| Total assets | SEK 169,7M | +32% |
| Equity | SEK 17M | +13% |
| Employees | 115 | — |
Legal name
Antaros Medical AB
Org number
5569769457
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
4 juli 2014
Share capital
SEK 101 000
Employees
115 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av Hulthe, Sven Wenzel Johannes i förening med en av Lindberg, Dan-Alp Olbe, Lars Richard Bertil Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolaget ska bedriva verksamhet med kliniska studier, konsultationer inom läkemedelsutveckling, utveckling av läkemedel samt handel med aktier och andelar jämte därmed förenlig verksamhet.
Address
Förändringens Gata 10
Phone
+46705661676
Email
dan-alp.lindberg@antarosmedical.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 64 049 | 90 551 | 98 212 | 116 713 | 142 655 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 6 167 | 9 160 | 2 509 | 8 585 | 20 330 |
| Depreciation & amort. | −2 775 | −5 235 | −7 463 | −9 369 | −10 118 |
| EBIT | 3 392 | 3 925 | −4 954 | −784 | 10 212 |
| Net financials | −395 | −218 | −299 | −1 431 | −6 780 |
| Profit before tax | 2 248 | 2 757 | −128 | −3 015 | 2 531 |
| Tax | −478 | −588 | −97 | −500 | −588 |
| Net profit | 1 770 | 2 169 | −225 | −3 515 | 1 943 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 59 548 | 81 183 | 87 321 | 128 445 | 169 650 |
| Equity | 11 462 | 13 631 | 13 406 | 15 012 | 16 956 |
| Long-term debt | 8 216 | 18 302 | 33 430 | 50 504 | 51 949 |
| Short-term debt | 35 695 | 44 125 | 40 484 | 62 129 | 99 045 |
| Total debt | 43 911 | 62 427 | 73 914 | 112 633 | 150 994 |
EBITDA margin
14.3%
This company
15.8%
Market median
-9% vs market
20202024
Equity ratio
10.0%
This company
38.2%
Market median
-74% vs market
20202024
Return on equity
11.5%
This company
18.4%
Market median
+37% vs market
20202024
Net profit margin
1.4%
This company
8.1%
Market median
-83% vs market
20202024
Asset turnover
0.84×
This company
1.12×
Market median
+25% vs market
20202024
Debt / equity
9.01×
This company
0.62×
Market median
-1353% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MF Chief Auditor | Chief Auditor | 2022 |
LR Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (2) | ||
ST Chief Auditor | Chief Auditor | 2021 – 2022 |
JE | Audit | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Former (6) | ||
| Chairman | 2020 – 2021 | |
| Board of Directors | 2020 – 2025 | |
| Chairman | 2021 – 2025 | |
| Board of Directors | 2020 – 2020 | |
| Board of Directors | 2020 – 2020 | |
| Board of Directors | 2020 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Antaros Holding AB
Antaros Medical AB Board members of Antaros Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Magnus Fjellman | Chief Auditor | 0 companies |
| Sven Tiberiu Cristea | Chief Auditor | 0 companies |
| Lars Richard Bertil Olbe | Chief Executive Officer | 0 companies |
| John Erik Andreas Österlund | Audit | 0 companies |
| Lars Olof Mikael Johansson | Chairman | 0 companies |
| Bo Henning Lennart Johnson | Board of Directors | 0 companies |
| Dan-Alp Lindberg | Board of Directors | 0 companies |
| Tor Simon Angeldorff | Chairman | 0 companies |
| Sven Wenzel Johannes Hulthe | Chairman | 0 companies |
| Karl Håkan Ahlström | Board of Directors | 0 companies |
| Karl Joel Kullberg | Board of Directors | 0 companies |
| Anna Carina Schmidt | Board of Directors | 0 companies |